Sinclair Pharma (XPAR:SPH) YoY EBITDA Growth : -125.00% (As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is Sinclair Pharma YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Sinclair Pharma's YoY EBITDA Growth for the quarter that ended in Jun. 2018 was -125.00%.

Sinclair Pharma's EBITDA per Share for the six months ended in Jun. 2018 was €-0.02.

Sinclair Pharma YoY EBITDA Growth Historical Data

The historical data trend for Sinclair Pharma's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinclair Pharma YoY EBITDA Growth Chart

Sinclair Pharma Annual Data

Trend

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Dec17

YoY EBITDA Growth

Get a 7-Day Free Trial

100.00

157.58

-194.74

150.00

Sinclair Pharma Semi-Annual Data
	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Jun17	Dec17	Jun18
YoY EBITDA Growth	Get a 7-Day Free Trial															-100.00	-	82.61	128.57	-125.00

Sinclair Pharma YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Sinclair Pharma's YoY EBITDA Growth for the fiscal year that ended in Dec. 2017 is calculated as:

	YoY EBITDA Growth (A: Dec. 2017 )
=	(EBITDA per Share (A: Dec. 2017 )	-	EBITDA per Share (A: Jun. 2015 ))	/	\| EBITDA per Share (A: Jun. 2015 ) \|
=	(0.009	-	-0.018)	/	\| -0.018 \|
=	150.00 %

Sinclair Pharma's YoY EBITDA Growth for the quarter that ended in Jun. 2018 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2018 )
=	(EBITDA per Share (Q: Jun. 2018 )	-	EBITDA per Share (Q: Jun. 2017 ))	/	\| EBITDA per Share (Q: Jun. 2017 )) \|
=	(-0.018	-	-0.008)	/	\| -0.008 \|
=	-125.00 %

Sinclair Pharma YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinclair Pharma (XPAR:SPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.sinclairispharma.com

Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.